Pharmaceutical procurement among public sector procurers in CARICOM
Rev Panam Salud Publica
; 45, may 2021
Artigo
em Inglês
| PAHO-IRIS
| ID: phr-53910
Biblioteca responsável:
US1.1
ABSTRACT
[ABSTRACT]. Objective. To examine multiple aspects of the medicines in CARICOM procurement markets, including manufacturer headquarters location, regulatory history, and type (innovator versus generic); the proportion of World Health Organization (WHO) essential medicines; and the most expensive medicines procured. Methods. An analysis of procurement information from selected CARICOM procurers. Four public sector procurement lists were obtained based on public availability or sharing of data from public sector procurers. Analyses were based on parameters available or deduced from these data. Results. The majority of products come from manufacturers headquartered in North America and Europe (63%–67%). The percentage of medicines procured from generic companies is 60%–87%; and 25%–50% of medicines procured are on the WHO Essential Medicines List. Wide price variations exist in the most expensive medicines purchased. Conclusions. The analysis identifies vulnerabilities and opportunities in the procurement situation of CARICOM states, particularly related to quality and rational use of medicines. This analysis represents a baseline that governments and other stakeholders can use in the future.
Texto completo:
Disponível
Coleções:
Bases de dados de organismos internacionais
Contexto em Saúde:
Agenda de Saúde Sustentável para as Américas
/
ODS3 - Saúde e Bem-Estar
Problema de saúde:
Objetivo 5 Medicamentos, vacinas e tecnologias sanitárias
/
Meta 3.8 Atingir a cobertura universal de saúde
Base de dados:
PAHO-IRIS
Assunto principal:
Farmacoeconomia
/
Região do Caribe
/
Indústria Farmacêutica
/
Comercialização de Medicamentos
/
Acesso a Medicamentos Essenciais e Tecnologias em Saúde
Tipo de estudo:
Avaliação econômica em saúde
/
Estudo prognóstico
Idioma:
Inglês
Ano de publicação:
2021
Tipo de documento:
Artigo